Novo Nordisk launches Brazil digital pharmacy and brings Wegovy to Peru

Novo Nordisk introduced NovoCare Farmácia, a digital pharmacy platform in Brazil operated with AS Medicamentos. The service lets patients purchase Ozempic, Wegovy and Rybelsus online after a prescription is verified through the platform, complying with ANVISA regulations. The pharmacy is part of the NovoCare ecosystem, which provides scientific information, specialist connections and support programmes such as NovoDia, offering price discounts and multidisciplinary care.

In Peru, Novo Nordisk announced the market entry of Wegovy (semaglutide 2.4 mg) for chronic obesity management. The launch is accompanied by the "Vive Ligero" initiative, aimed at reducing stigma and promoting a science‑based conversation about obesity. The drug will be priced at S/ 541 and is supported by the "Novo te Cuida" digital platform that offers education, medical guidance and tools to improve treatment adherence. Executives highlighted the company's commitment to expanding therapeutic options for obesity and diabetes across South America.